상품명칭 |
()-2-[4-[3-[[4-벤즈아미도-5-(디프로필아미노)글루타릴]옥시]프로필]-1-피페라지닐]에틸 1-(p-클로로벤조일)-5-메톡시-2-메틸-1H-인돌-3-아세테이트, 말레산 화합물(1:2) |
별명 |
;P 로글루메타신 디 말레 에이트; 프로타신; 아플록산; 크롬-604; 프로글루메타신 말레산염; Proglumetacina [스페인어]; (1)-2-(4-(3-((4-벤즈아미도-5-(디프로필아미노)글루타릴)옥시)프로필)-1-피페라지닐)에틸 1-(p-클로로벤조일)-5-메톡시-2-메틸-1H-인돌-3-아세테이트, 말레산 화합물(1:2); 1H-인돌-3-아세트산, 1-(4-클로로벤조일)-5-메톡시-2-메틸-2-(4-(3-((4-(벤조일아미노)-5-(디프로필아미노)-1,5-디옥소펜틸)옥시)프로필)-1-피페라지닐)에틸 에스테르( -)-, (Z)-2-부텐디오에이트(1:2); 3'-(4-(2-(1-p-클로로벤조일-5-메톡시-2-메틸인돌-3-일아세톡시)에틸)피페라진-1-일)프로필-4-벤즈아미도-N,N-디프로필글루타라메이트( -)디말레에이트 |
영문 이름 |
()-2-[4-[3-[[4-benzamido-5-(dipropylamino)glutaryl]oxy]propyl]-1-piperazinyl]ethyl 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate, compound with maleic acid (1:2); Proglumetacin dimaleate; Protacine; Afloxan; CR-604; Proglumetacin maleate; Proglumetacina [Spanish]; (1)-2-(4-(3-((4-Benzamido-5-(dipropylamino)glutaryl)oxy)propyl)-1-piperazinyl)ethyl 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate, compound with maleic acid (1:2); 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-2-(4-(3-((4-(benzoylamino)-5-(dipropylamino)-1,5-dioxopentyl)oxy)propyl)-1-piperazinyl)ethyl ester (+-)-, (Z)-2-butenedioate (1:2); 3'-(4-(2-(1-p-Chlorobenzoyl-5-methoxy-2-methylindol-3-ylacetoxy)ethyl)piperazin-1-yl)propyl-4-benzamido-N,N-dipropylglutaramate (+-) dimaleate |
분자식 |
C46H58ClN5O8・2C4H4O4 |
분자량 |
960.516 |
InChI |
InChI=1/C46H58ClN5O8.C4H4O4/c1-5-21-51(22-6-2)46(57)40(48-44(55)34-11-8-7-9-12-34)18-20-42(53)59-29-10-23-49-24-26-50(27-25-49)28-30-60-43(54)32-38-33(3)52(41-19-17-37(58-4)31-39(38)41)45(56)35-13-15-36(47)16-14-35;5-3(6)1-2-4(7)8/h7-9,11-17,19,31,40H,5-6,10,18,20-30,32H2,1-4H3,(H,48,55);1-2H,(H,5,6)(H,7,8)/b;2-1- |
cas번호 |
59209-40-4 |
EC번호 |
261-656-3 |
분자 구조 |
|
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|